IRIS
COSTA, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.379
NA - Nord America 4.682
EU - Europa 3.594
SA - Sud America 714
AF - Africa 135
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.520
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.466
SG - Singapore 2.974
RU - Federazione Russa 1.795
CN - Cina 1.187
VN - Vietnam 1.069
IT - Italia 614
BR - Brasile 567
HK - Hong Kong 545
FR - Francia 306
DE - Germania 181
NL - Olanda 162
JP - Giappone 133
CA - Canada 119
IE - Irlanda 118
FI - Finlandia 113
IN - India 99
GB - Regno Unito 80
BD - Bangladesh 72
KR - Corea 58
AR - Argentina 52
MX - Messico 49
IQ - Iraq 42
SE - Svezia 42
ZA - Sudafrica 37
ES - Italia 35
PH - Filippine 28
UA - Ucraina 28
CI - Costa d'Avorio 24
EC - Ecuador 23
PL - Polonia 23
TR - Turchia 22
TH - Thailandia 19
ID - Indonesia 18
VE - Venezuela 18
AT - Austria 16
CO - Colombia 15
PK - Pakistan 15
TW - Taiwan 15
MA - Marocco 14
PY - Paraguay 14
SA - Arabia Saudita 13
UZ - Uzbekistan 12
CL - Cile 11
LT - Lituania 11
TN - Tunisia 10
AU - Australia 9
CH - Svizzera 9
JM - Giamaica 9
BE - Belgio 8
CZ - Repubblica Ceca 8
EG - Egitto 8
JO - Giordania 8
PE - Perù 8
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
LB - Libano 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
HU - Ungheria 5
NP - Nepal 5
PA - Panama 5
RO - Romania 5
BH - Bahrain 4
ET - Etiopia 4
GA - Gabon 4
GR - Grecia 4
GT - Guatemala 4
IL - Israele 4
KE - Kenya 4
MN - Mongolia 4
MY - Malesia 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
CG - Congo 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
HR - Croazia 3
NI - Nicaragua 3
PR - Porto Rico 3
UY - Uruguay 3
BS - Bahamas 2
EU - Europa 2
GF - Guiana Francese 2
GM - Gambi 2
GN - Guinea 2
GP - Guadalupe 2
HN - Honduras 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 15.494
Salva come PNG Salva come JPEG
Città #
Singapore 1.403
San Jose 745
Hong Kong 525
Moscow 472
Ashburn 462
Ho Chi Minh City 339
Beijing 288
Santa Clara 269
Hefei 254
Chandler 249
Hanoi 237
The Dalles 198
Lauterbourg 157
Naples 154
Millbury 145
Tokyo 124
Amsterdam 118
Los Angeles 116
Des Moines 102
Boston 98
Princeton 90
Napoli 81
Buffalo 80
Nanjing 72
Redondo Beach 68
New York 64
Lawrence 57
Dallas 55
Ottawa 49
Munich 48
São Paulo 46
Seoul 45
Da Nang 42
Wilmington 41
Frankfurt am Main 37
Orem 33
Rome 32
Haiphong 31
Milan 31
Mexico City 26
Turku 25
Brooklyn 24
Chicago 24
Dublin 24
Helsinki 24
Nanchang 24
Seattle 24
Cava de' Tirreni 23
Hải Dương 22
Johannesburg 20
Toronto 20
Denver 19
Falkenstein 19
Montreal 19
Phoenix 19
Baghdad 18
Hangzhou 18
Washington 18
Chennai 17
Atlanta 16
New Delhi 16
Belo Horizonte 15
Biên Hòa 15
Council Bluffs 15
Warsaw 15
Boardman 14
Jacksonville 14
San Francisco 14
Shanghai 14
Can Tho 13
Hebei 13
Shenyang 13
Ankara 12
Dong Ket 12
Houston 12
London 12
Redwood City 12
Woodbridge 12
Fairfield 11
Guangzhou 11
Nuremberg 11
Poplar 11
Rio de Janeiro 11
Brasília 10
Guayaquil 10
Hyderabad 10
Jiaxing 10
Manchester 10
Phủ Lý 10
Porto Alegre 10
Salvador 10
Tashkent 10
Tianjin 10
Bến Tre 9
Changsha 9
Ribeirão Preto 9
Vienna 9
Amman 8
Campinas 8
Kunming 8
Totale 8.358
Salva come PNG Salva come JPEG
Nome #
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 198
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 164
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 160
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 148
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 145
Fragility Fractures in Patients with Psoriatic Arthritis 143
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 139
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 139
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. 138
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 138
Psoriatic arthritis and psoriasis: differential diagnosis 135
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 133
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 132
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 131
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 126
Small molecule therapy for managing moderate to severe psoriatic arthritis 124
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 124
Dactylitis in enteropathic spondyloarthritis 122
Magnetic resonance imaging of nail unit in psoriatic arthritis 122
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 121
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 120
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 119
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 119
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 118
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 118
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 118
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 118
La gravidanza nelle malattie autoimmuni: il rischio per la madre, per il feto e per il neonato. 117
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 117
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 116
Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor-α Blockers for Psoriatic Arthritis 116
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 116
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease 115
Serum amyloid-A in Beh?et's disease. 115
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 115
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 115
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 114
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 112
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 112
Epidemiologia ed aspetti socioeconomici dell’osteoporosi. 111
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 111
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 110
Simple clinical indicators for early psoriatic arthritis detection 110
JAK Inhibitors in Psoriatic Disease 109
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 109
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 109
Treatment options: NSAIDs and DMARDs 109
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 109
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 108
Biological treatments in Behçet's disease: beyond anti-TNF therapy 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers 107
Osteoporosis and psoriatic arthritis. 106
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 105
Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: The ULISSE study 105
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 103
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 102
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 102
The definition and measurement of axial psoriatic arthritis 102
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 102
New developments in magnetic resonance imaging of the nail unit. 101
The ClASsification for Psoriatic ARthritis (CASPAR) Criteria - A Retrospective Feasibility, Sensitivity, and Specificity Study 101
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 101
The enthesopathy of celiac patients: Effects of gluten-free diet 101
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 100
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 100
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 99
The enthesopathy of celiac patients: effects of gluten-free diet 98
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 98
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 97
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 97
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 97
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 96
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 95
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 94
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 94
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 93
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 92
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 92
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 92
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis 91
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. 91
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 90
Blau syndrome and latent tubercular infection: an unresolved partnership 89
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 87
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 87
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 87
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease 86
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 86
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 85
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. 85
Emerging drugs for psoriatic arthritis 85
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 85
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 84
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 84
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain 84
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 83
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 82
Early Psoriatic Arthritis 78
Totale 10.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022686 8 8 2 0 2 30 1 32 106 33 124 340
2022/2023764 148 23 24 38 91 78 5 73 95 114 65 10
2023/2024720 31 113 116 49 38 87 21 44 7 12 126 76
2024/20254.473 314 299 22 79 80 297 455 283 375 455 1.427 387
2025/20268.129 956 705 849 762 1.288 369 875 651 1.013 422 197 42
Totale 15.796